Veterinary Immunodiagnostics Market to Grow with a CAGR of 7.98% through 2031

Growing number of veterinary practitioners is driving the growth of Global Veterinary Immunodiagnostics Market, in the forecast period, 2021-2031.

According to TechSci Research report, “Global Veterinary Immunodiagnostics Market By Product Type (Analyzers, Consumables) By Animal Type (Livestock (Cattle, Pigs, Poultry, Others), Companion (Feline, Equine, Canine, Others) By Technology (ELISA, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Colorimetric Immunoassay), Radioimmunoassay, Rapid Tests, Others)  By Application (Infectious Disease, Autoimmune Disorder, Endocrinology, Oncology, Bone and Mineral Diseases, Others) By End User (Reference Laboratories, Academic and Research Institutes, Veterinary Hospitals & Clinics, Point of care/In-house testing) By Distribution Channel (Hospitals, Retail Stores, Pharmacies & Drug Stores and E-Commerce) By Region, Competition Forecast & Opportunities, 2031”, the Global Veterinary Immunodiagnostics Market will grow from USD 2.94 Billion in 2025 to USD 4.66 Billion by 2031 at a 7.98% CAGR. The global veterinary immunodiagnostics market is expanding steadily, driven by growing emphasis on early detection of zoonotic diseases, rising awareness of animal health, and increasing demand for animal-derived food products. The last decade has seen a surge in adoption of advanced diagnostic technologies for both companion and livestock animals, as veterinarians and pet owners alike prioritize timely and accurate disease identification. Early diagnostics are crucial not only to safeguard animal welfare but also to prevent cross-species transmission of pathogens to humans a factor that has gained significant global attention following recent zoonotic outbreaks.

Browse over XX market data Figures spread through 110 Pages and an in-depth TOC on "Global Veterinary Immunodiagnostics Market"

The market’s growth is further supported by a steady rise in pet ownership, particularly in emerging economies such as India, China, and Brazil. Urbanization and rising disposable incomes have fueled higher spending on companion animals, encouraging regular health checkups, vaccinations, and diagnostic tests. Governments and animal welfare organizations are also allocating greater resources toward enhancing veterinary infrastructure and implementing surveillance programs for livestock diseases, ensuring food safety and trade compliance. Initiatives such as the World Organisation for Animal Health (WOAH) disease monitoring programs and national-level livestock vaccination drives have strengthened diagnostic demand worldwide.

Technological innovation continues to transform veterinary immunodiagnostics. The market is increasingly adopting advanced testing platforms, including enzyme-linked immunosorbent assays (ELISA), lateral flow assays, and chemiluminescence immunoassays, to detect a wide range of infectious and chronic diseases in animals. Recent advancements have introduced point-of-care (POC) diagnostic kits that deliver rapid and accurate results in field conditions, significantly benefiting rural veterinary practices and animal husbandry sectors. Moreover, the integration of artificial intelligence and data analytics into diagnostic platforms allows for improved disease pattern recognition, early detection, and data-driven decision-making in clinical and herd management applications.

The COVID-19 pandemic reshaped the veterinary diagnostics landscape by underscoring the interconnectedness of animal and human health. The global health crisis caused by a zoonotic virus  intensified investments in veterinary research, biosurveillance, and diagnostic innovations to prevent future outbreaks. While initial lockdowns disrupted supply chains and limited access to veterinary testing services, the post-pandemic recovery brought renewed attention to veterinary laboratories, biosafety, and disease control programs. This surge in awareness of “One Health”  the integrated human-animal-environment health approach has become a major international driver for the veterinary immunodiagnostics industry.

Leading companies operating in the global market include IDEXX Laboratories Inc., Zoetis Inc., Thermo Fisher Scientific Inc., bioMérieux SA, Heska Corporation, Neogen Corporation, Bio-Rad Laboratories Inc., Agrolabo SpA, Virbac SA, and Randox Laboratories Ltd. These players are focusing on R&D activities, product expansions, strategic partnerships with veterinary institutions, and acquisitions to broaden their diagnostic portfolios. Their innovations center around multiplex testing, digital data integration, and portable systems designed for both clinical and field-level use. With continuous advancements in test accuracy, automation, and pathogen-specific kit availability, the global veterinary immunodiagnostics market is anticipated to maintain robust growth, supporting animal disease management, public health safety, and sustainable livestock development in the years ahead..

The global veterinary immunodiagnostics market is segmented by product type, animal type, technology, application, end user, distribution channel, regional distribution, and competitional landscape. Based on technology, the market is further fragmented into ELISA, chemiluminescence immunoassay, fluorescent immunoassay, colorimetric immunoassay, radioimmunoassay, rapid tests, and others. Enzyme Linked Immunosorbent Assay (ELISA) is a plate based, technique that detects and quantifies disease causing proteins and peptides, to identify the presence of a prospected disease. Chemiluminescence immunoassay, fluorescent immunoassay, colorimetric immunoassay are variant versions of ELISA that is used for the diagnostics for veterinary diseases. Radioimmunoassay is the process to identify the diseased proteins through radiolabeled molecules in a stepwise formation of the degrading immune system in livestock and companion animal population. These methods are actively incorporated for the veterinary immunodiagnostics purposes, although the [procedures are complex and expenses, but they are actively used and thus supporting the growth of the global veterinary immunodiagnostics market in the upcoming five years.

Some of the major competitors in the market are Abaxis Inc., BioMerieux SA, Idexx Laboratories Corporation, Heska Corporation, Virbac SA, Zoetis Inc., Woodley Veterinary Diagnostics Ltd., Randox Laboratories Ltd., Neogen Corporation, Thermo Fisher Scientific Inc., among others. The companies are focusing on extensive research and developments activities to stay competitive in the market. Other competitive strategies include formation of alliances and partnerships.

Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7352

Customers can also request for 10% free customization on this report.

“The market has a promising future in the Asia-Pacific region, owing to the facts like rising pet-ownership, increased preference of animal related food products, and need to provide better healthcare services for the livestock and companion animal populations. North America region has higher pet population and better health services for them thus dominating the market in the forecast period. Governmental aids and new investments would support the market further,” said Mr. Karan Chechi, Research Director with TechSci Research, a research based Global management consulting firm.

“Global Veterinary Immunodiagnostics Market By Product Type (Analyzers, Consumables) By Animal Type (Livestock (Cattle, Pigs, Poultry, Others), Companion (Feline, Equine, Canine, Others) By Technology (ELISA, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Colorimetric Immunoassay), Radioimmunoassay, Rapid Tests, Others) By Application (Infectious Disease, Autoimmune Disorder, Endocrinology, Oncology, Bone and Mineral Diseases, Others) By End User (Reference Laboratories, Academic and Research Institutes, Veterinary Hospitals & Clinics, Point of care/In-house testing) By Distribution Channel (Hospitals, Retail Stores, Pharmacies & Drug Stores and E-Commerce) By Region, Competition Forecast & Opportunities, 2021-2031F”, has evaluated the future growth potential of Global Veterinary Immunodiagnostics and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Veterinary Immunodiagnostics.

Contact

Mr. Ken Mathews

708 Third Avenue,

Manhattan, NY,

New York – 10017

Tel: +1-646-360-1656

Email: [email protected]

Website: https://www.techsciresearch.com/